Article Details

Tecentriq-Lurbinectedin Phase 3 Trial Success in Lung Cancer | RHHBY Stock News

Retrieved on: 2025-06-02 20:20:13

Tags for this article:

Click the tags to see associated articles and topics

Tecentriq-Lurbinectedin Phase 3 Trial Success in Lung Cancer | RHHBY Stock News. View article details on hiswai:

Excerpt

--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III IMforte ...

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo